The Bioinformatics & Biotechnology Shared Resource provides a broad range of chemistry, biomolecular, and bioinformatics services and expertise in support of Cancer Center research programs. It includes six sections: Bioinformatics, High-throughput DNA Sequencing and Genotyping, Macromolecular Synthesis, Functional Genomics, Clinical Applications Core Technology (CACT), and Proteomics. Bioinformatics provides investigators with access to high-performance computing resources, bioinformatics software, and all major public biomolecular databases. Highthroughput DNA Sequencing & Genotyping provides investigators with access to automated DNA sequence analysis, fragment size analysis, and SNP detection technologies. Macromolecular Synthesis provides synthetic peptides and synthetic oligonucleotides to Cancer Center investigators (CCSG support is not be requested for this section). Functional Genomics provides cDNA microarray services and analyses to Center investigators. The Clinical Applications Core Technology section provides oligonucleotide-based microarray analysis (Affymetrix, Inc.) for investigators. (Functional Genomics and the CACT laboratory activities will be combined in this application). Proteomics offers a range of protein chemistry capabilities including protein sequence analysis using Edman chemistry, protein identification using mass spectrometry, and protein interaction analysis using surface plasmon resonance technology. All sections are highly integrated and readily accessible using our Web-based on-line ordering and tracking system and a comprehensive relational database system housing all chemistry information. The projected total budget for this Shared Resource in year-25 of this grant is $4,089,971 of which 12% ($498,763) is requested from the CCSG; the remainder of the budget (88%, $3,591,208) will be provided by SJCRH institutional funds and by chargeback to individual investigators. Over 80% of the usage of this Shared Resource is by Cancer Center members for peer-reviewed projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6602692
Study Section
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Devine, Katie A; Mertens, Ann C; Whitton, John A et al. (2018) Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: A report from the childhood cancer survivor study (CCSS). Psychooncology 27:613-619
Matreyek, Kenneth A; Starita, Lea M; Stephany, Jason J et al. (2018) Multiplex assessment of protein variant abundance by massively parallel sequencing. Nat Genet 50:874-882
Hazlitt, Robert A; Min, Jaeki; Zuo, Jian (2018) Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss. J Med Chem 61:5512-5524
Hoehn, Mary Ellen; Calderwood, Julie; Gannon, Edwin et al. (2018) Ocular complications in a young pediatric population following bone marrow transplantation. J AAPOS 22:102-106.e1
Zimmerman, Mark W; Liu, Yu; He, Shuning et al. (2018) MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification. Cancer Discov 8:320-335
Hammill, Jared T; Bhasin, Deepak; Scott, Daniel C et al. (2018) Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation. J Med Chem 61:2694-2706
Li, Yanfeng; Bakke, Jesse; Finkelstein, David et al. (2018) HNRNPH1 is required for rhabdomyosarcoma cell growth and survival. Oncogenesis 7:9
Khan, Raja B; Merchant, Thomas E; Sadighi, Zsila S et al. (2018) Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors. J Neurooncol 136:379-384
Ma, Xiaotu; Liu, Yu; Liu, Yanling et al. (2018) Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555:371-376
Broniscer, Alberto; Jia, Sujuan; Mandrell, Belinda et al. (2018) Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma. Pediatr Blood Cancer 65:e27035

Showing the most recent 10 out of 6764 publications